SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-129592
Filing Date
2024-12-18
Accepted
2024-12-18 07:10:59
Documents
20
Period of Report
2024-12-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2430949d2_8k.htm   iXBRL 8-K 33045
2 EXHIBIT 4.1 tm2430949d2_ex4-1.htm EX-4.1 758462
6 GRAPHIC tm2430949d2_ex4-1img007.jpg GRAPHIC 2359
7 GRAPHIC tm2430949d2_ex4-1img008.jpg GRAPHIC 2945
8 GRAPHIC tm2430949d2_ex4-1img001.jpg GRAPHIC 11080
9 GRAPHIC tm2430949d2_ex4-1img003.jpg GRAPHIC 12484
10 GRAPHIC tm2430949d2_ex4-1img004.jpg GRAPHIC 10213
11 GRAPHIC tm2430949d2_ex4-1img005.jpg GRAPHIC 15696
  Complete submission text file 0001104659-24-129592.txt   1194122

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA espr-20241217.xsd EX-101.SCH 3015
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE espr-20241217_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE espr-20241217_pre.xml EX-101.PRE 22359
22 EXTRACTED XBRL INSTANCE DOCUMENT tm2430949d2_8k_htm.xml XML 3697
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35986 | Film No.: 241557592
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)